DYN(DYN)
DYN
DYN Fundamentals
Annual and trailing 12-month valuesDYN News
About
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.
Leadership (11)
Douglas KerrHead of Research & Development and Chief Medical Officer
Oxana BeskrovnayaChief Innovation Officer
Rajesh ManchandaChief Technical Officer
Alessandro MartuscelliChief Legal Officer
Erick J. LuceraChief Financial Officer, Principal Financial Officer & Principal Accounting Officer and Treasurer
James BilottaChief Digital & Information Officer
John G. CoxChief Executive Officer, President & Director
Debra FeldmanChief Regulatory Affairs Officer
Johanna Friedl-NadererChief Commercial Officer
Lucia CelonaChief Human Resource Officer
Axel WiestSenior VP and Head of Portfolio Strategy & Operations
Explore More
DYN Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
